Delivery Order SPE2DB20D6035-SPE2DB24FLXEF
Award Date
8/23/24
Potential Completion Date
9/16/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,816.32, is a delivery order for 4567143430 RYANODEX 250 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $8,937.84 and an ultimate completion date of May 21, 2024. Amerisourcebergen Drug Corp, which is registered in SAM.gov through June 11, 2025, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,421.76 firm-fixed-price contract is for the supply of RYANODEX 250 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM5G7 and a ceiling value of $24,081.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, to support federal government agencies. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The $2,979.28 firm-fixed-price contract has a completion date of July 11, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical...
This federal contract award, valued at $4,816.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a specific medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 21, 2025. The contract award is not designated with a set-aside requirement, indicating an...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,605.44, is for the delivery of RYANODEX 250MG VIAL 1S medical supplies. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,716.40 and is a firm fixed-price delivery order, with an ultimate completion date of September 26, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract does not have a set-aside designation,...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $22,476.16. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product, to support military healthcare programs. The IDC with the DLA Troop Support Medical has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and...